176 related articles for article (PubMed ID: 23012327)
1. Chemokine-mediated tissue recruitment of CXCR3+ CD4+ T cells plays a major role in the pathogenesis of chronic GVHD.
Croudace JE; Inman CF; Abbotts BE; Nagra S; Nunnick J; Mahendra P; Craddock C; Malladi R; Moss PA
Blood; 2012 Nov; 120(20):4246-55. PubMed ID: 23012327
[TBL] [Abstract][Full Text] [Related]
2. CXCL10-CXCR3 interactions play an important role in the pathogenesis of acute graft-versus-host disease in the skin following allogeneic stem-cell transplantation.
Piper KP; Horlock C; Curnow SJ; Arrazi J; Nicholls S; Mahendra P; Craddock C; Moss PA
Blood; 2007 Dec; 110(12):3827-32. PubMed ID: 17766680
[TBL] [Abstract][Full Text] [Related]
3. CXCR3 Ligands in Cancer and Autoimmunity, Chemoattraction of Effector T Cells, and Beyond.
Karin N
Front Immunol; 2020; 11():976. PubMed ID: 32547545
[TBL] [Abstract][Full Text] [Related]
4. Serum chemokine receptor CXCR3 ligands are associated with progression, organ dysfunction and complications of chronic liver diseases.
Tacke F; Zimmermann HW; Berres ML; Trautwein C; Wasmuth HE
Liver Int; 2011 Jul; 31(6):840-9. PubMed ID: 21645215
[TBL] [Abstract][Full Text] [Related]
5. Wrinkle in the plan: miR-34a-5p impacts chemokine signaling by modulating CXCL10/CXCL11/CXCR3-axis in CD4
Hart M; Nickl L; Walch-Rueckheim B; Krammes L; Rheinheimer S; Diener C; Taenzer T; Kehl T; Sester M; Lenhof HP; Keller A; Meese E
J Immunother Cancer; 2020 Nov; 8(2):. PubMed ID: 33229509
[TBL] [Abstract][Full Text] [Related]
6. Expression of CXCR3 and its ligands CXCL9, -10 and -11 in paediatric opsoclonus-myoclonus syndrome.
Pranzatelli MR; Tate ED; McGee NR; Travelstead AL; Verhulst SJ; Ransohoff RM
Clin Exp Immunol; 2013 Jun; 172(3):427-36. PubMed ID: 23600831
[TBL] [Abstract][Full Text] [Related]
7. Herpes Simplex Virus Type 2 Infection-Induced Expression of CXCR3 Ligands Promotes CD4
Zhang M; Deng X; Guan X; Geng L; Fu M; Zhang B; Chen R; Hu H; Hu K; Zhang D; Li M; Liu Y; Gong S; Hu Q
Front Immunol; 2018; 9():2932. PubMed ID: 30619292
[TBL] [Abstract][Full Text] [Related]
8. CXCL9, but not CXCL10, promotes CXCR3-dependent immune-mediated kidney disease.
Menke J; Zeller GC; Kikawada E; Means TK; Huang XR; Lan HY; Lu B; Farber J; Luster AD; Kelley VR
J Am Soc Nephrol; 2008 Jun; 19(6):1177-89. PubMed ID: 18337479
[TBL] [Abstract][Full Text] [Related]
9. CXCR3 and CCR5 chemokines in induced sputum from patients with COPD.
Costa C; Rufino R; Traves SL; Lapa E Silva JR; Barnes PJ; Donnelly LE
Chest; 2008 Jan; 133(1):26-33. PubMed ID: 17925429
[TBL] [Abstract][Full Text] [Related]
10. Critical role for CXCR3 chemokine biology in the pathogenesis of bronchiolitis obliterans syndrome.
Belperio JA; Keane MP; Burdick MD; Lynch JP; Xue YY; Li K; Ross DJ; Strieter RM
J Immunol; 2002 Jul; 169(2):1037-49. PubMed ID: 12097412
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-27 and IFNγ regulate the expression of CXCL9, CXCL10, and CXCL11 in hepatitis.
Basset L; Chevalier S; Danger Y; Arshad MI; Piquet-Pellorce C; Gascan H; Samson M
J Mol Med (Berl); 2015 Dec; 93(12):1355-67. PubMed ID: 26199110
[TBL] [Abstract][Full Text] [Related]
12. Regulatory T cells inhibit CD8(+) T-cell tissue invasion in human skin graft-versus-host reactions.
Mavin E; Ahmed SS; O'Boyle G; Turner B; Douglass S; Norden J; Collin M; Ali S; Dickinson A; Wang XN
Transplantation; 2012 Sep; 94(5):456-64. PubMed ID: 22890131
[TBL] [Abstract][Full Text] [Related]
13. Serum levels of CXCR3 ligands predict T cell-mediated acute rejection after kidney transplantation.
Huang H; Xu X; Yao C; Cai M; Qian Y; Wang X; Shi B
Mol Med Rep; 2014 Jan; 9(1):45-50. PubMed ID: 24154640
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic effect of CXCR3-expressing regulatory T cells on liver, lung and intestinal damages in a murine acute GVHD model.
Hasegawa H; Inoue A; Kohno M; Lei J; Miyazaki T; Yoshie O; Nose M; Yasukawa M
Gene Ther; 2008 Feb; 15(3):171-82. PubMed ID: 17989707
[TBL] [Abstract][Full Text] [Related]
15. Bu-Shen-Fang-Chuan formula attenuates T-lymphocytes recruitment in the lung of rats with COPD through suppressing CXCL9/CXCL10/CXCL11-CXCR3 axis.
Li Q; Sun J; Cao Y; Liu B; Li L; Mohammadtursun N; Zhang H; Dong J; Wu J
Biomed Pharmacother; 2020 Mar; 123():109735. PubMed ID: 31864210
[TBL] [Abstract][Full Text] [Related]
16. Role of CXCR3/CXCL10 axis in immune cell recruitment into the small intestine in celiac disease.
Bondar C; Araya RE; Guzman L; Rua EC; Chopita N; Chirdo FG
PLoS One; 2014; 9(2):e89068. PubMed ID: 24586509
[TBL] [Abstract][Full Text] [Related]
17. Interferon-γ amplifies airway smooth muscle-mediated CD4+ T cell recruitment by promoting the secretion of C-X-C-motif chemokine receptor 3 ligands.
Sun R; Jang JH; Lauzon AM; Martin JG
FASEB J; 2021 Jan; 35(1):e21228. PubMed ID: 33337555
[TBL] [Abstract][Full Text] [Related]
18. Cross reactivity of three T cell attracting murine chemokines stimulating the CXC chemokine receptor CXCR3 and their induction in cultured cells and during allograft rejection.
Meyer M; Hensbergen PJ; van der Raaij-Helmer EM; Brandacher G; Margreiter R; Heufler C; Koch F; Narumi S; Werner ER; Colvin R; Luster AD; Tensen CP; Werner-Felmayer G
Eur J Immunol; 2001 Aug; 31(8):2521-7. PubMed ID: 11500837
[TBL] [Abstract][Full Text] [Related]
19. CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation - A target for novel cancer therapy.
Tokunaga R; Zhang W; Naseem M; Puccini A; Berger MD; Soni S; McSkane M; Baba H; Lenz HJ
Cancer Treat Rev; 2018 Feb; 63():40-47. PubMed ID: 29207310
[TBL] [Abstract][Full Text] [Related]
20. CXCR3 blockade combined with cyclosporine A alleviates acute graft-versus-host disease by inhibiting alloreactive donor T cell responses in a murine model.
Miao S; Tang B; Liu H; Wang Z; Shi Y; Dong Y; Liu W; Qin C; Ren H
Mol Immunol; 2018 Feb; 94():82-90. PubMed ID: 29288898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
